These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 17938973

  • 21. Use of mycophenolate mofetil in steroid-dependent and -resistant nephrotic syndrome.
    Barletta GM, Smoyer WE, Bunchman TE, Flynn JT, Kershaw DB.
    Pediatr Nephrol; 2003 Aug; 18(8):833-7. PubMed ID: 12774223
    [Abstract] [Full Text] [Related]

  • 22. Mycophenolate mofetil therapy for children with intractable nephrotic syndrome.
    Okada M, Sugimoto K, Yagi K, Yanagida H, Tabata N, Takemura T.
    Pediatr Int; 2007 Dec; 49(6):933-7. PubMed ID: 18045300
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Prospective controlled study on mycophenolate mofetil and prednisolone in the treatment of membranous nephropathy with nephrotic syndrome.
    Chan TM, Lin AW, Tang SC, Qian JQ, Lam MF, Ho YW, Tse KC, Chan KW, Lai KN, Tang CS.
    Nephrology (Carlton); 2007 Dec; 12(6):576-81. PubMed ID: 17995584
    [Abstract] [Full Text] [Related]

  • 27. Three year outcome of childhood idiopathic nephrotic syndrome under a unified immunosuppressive protocol.
    Hibino S, Uemura O, Nagai T, Yamakawa S, Iwata N, Ito H, Nakano M, Tanaka K.
    Pediatr Int; 2015 Dec; 57(1):85-91. PubMed ID: 25225083
    [Abstract] [Full Text] [Related]

  • 28. Mycophenolate mofetil in treatment of childhood steroid-resistant nephrotic syndrome.
    Gargah TT, Lakhoua MR.
    J Nephrol; 2011 Dec; 24(2):203-7. PubMed ID: 21319130
    [Abstract] [Full Text] [Related]

  • 29. Daily compared with alternate-day levamisole in pediatric nephrotic syndrome: an open-label randomized controlled study.
    Banerjee S, Sengupta J, Sinha R, Chatterjee S, Sarkar S, Akhtar S, Saha R, Pahari A.
    Pediatr Nephrol; 2024 Oct; 39(10):2969-2977. PubMed ID: 38822220
    [Abstract] [Full Text] [Related]

  • 30. Mycophenolate Mofetil after Rituximab for Childhood-Onset Complicated Frequently-Relapsing or Steroid-Dependent Nephrotic Syndrome.
    Iijima K, Sako M, Oba M, Tanaka S, Hamada R, Sakai T, Ohwada Y, Ninchoji T, Yamamura T, Machida H, Shima Y, Tanaka R, Kaito H, Araki Y, Morohashi T, Kumagai N, Gotoh Y, Ikezumi Y, Kubota T, Kamei K, Fujita N, Ohtsuka Y, Okamoto T, Yamada T, Tanaka E, Shimizu M, Horinochi T, Konishi A, Omori T, Nakanishi K, Ishikura K, Ito S, Nakamura H, Nozu K, Japanese Study Group of Kidney Disease in Children.
    J Am Soc Nephrol; 2022 Feb; 33(2):401-419. PubMed ID: 34880074
    [Abstract] [Full Text] [Related]

  • 31. Mycophenolate mofetil in children with steroid-dependent and/or frequently relapsing nephrotic syndrome.
    Al-Akash S, Al-Makdama A.
    Ann Saudi Med; 2005 Feb; 25(5):380-4. PubMed ID: 16270759
    [Abstract] [Full Text] [Related]

  • 32. Efficacy and safety of oral cyclophosphamide versus mycophenolate mofetil in childhood nephrotic syndrome: an open-label comparative study.
    Dhooria GS, Bhargava S, Bhat D, Pooni PA, Goel N, Kakkar S.
    BMC Nephrol; 2024 Sep 09; 25(1):296. PubMed ID: 39251984
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Sixteen-week versus standard eight-week prednisolone therapy for childhood nephrotic syndrome: the PREDNOS RCT.
    Webb NJ, Woolley RL, Lambe T, Frew E, Brettell EA, Barsoum EN, Trompeter RS, Cummins C, Wheatley K, Ives NJ.
    Health Technol Assess; 2019 May 09; 23(26):1-108. PubMed ID: 31156083
    [Abstract] [Full Text] [Related]

  • 35. Randomized clinical trial to compare efficacy and safety of repeated courses of rituximab to single-course rituximab followed by maintenance mycophenolate-mofetil in children with steroid dependent nephrotic syndrome.
    Basu B, Preussler S, Sander A, Mahapatra TKS, Schaefer F.
    BMC Nephrol; 2020 Nov 30; 21(1):520. PubMed ID: 33256621
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Efficacy of higher-dose levamisole in maintaining remission in steroid-dependant nephrotic syndrome.
    Abeyagunawardena AS, Karunadasa U, Jayaweera H, Thalgahagoda S, Tennakoon S, Abeyagunawardena S.
    Pediatr Nephrol; 2017 Aug 30; 32(8):1363-1367. PubMed ID: 28299461
    [Abstract] [Full Text] [Related]

  • 38. Efficacy of low-dose daily versus alternate-day prednisolone in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial.
    Yadav M, Sinha A, Khandelwal P, Hari P, Bagga A.
    Pediatr Nephrol; 2019 May 30; 34(5):829-835. PubMed ID: 30194663
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Mycophenolate mofetil versus cyclosporine A in children with primary refractory nephrotic syndrome].
    Geng HY, Ji LN, Chen CY, Tu J, Li HR, Bao R, Lin Y.
    Zhonghua Er Ke Za Zhi; 2018 Sep 02; 56(9):651-656. PubMed ID: 30180402
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.